Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Alpine Immune Sciences by Quarter
Alpine Immune Sciences — Total operating expenses ($M) ($M)
Vertex Pharmaceuticals Alpine Immune Sciences: $29.7M in Q1 2024, up 19.0% from a year earlier. That is the highest of the 25 quarters on record here. No newer figure appears in the documents we track.
Where the Q1 2024 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001626199 Alpine Immune Sciences).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Alpine Immune Sciences — Total operating expenses ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2024 | Mar 31, 2024 | 29.7 | +19.0% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 29.3 | +26.7% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 24.6 | +10.8% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 24.3 | +11.3% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 25.0 | +18.4% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 23.1 | +16.2% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 22.2 | +1.9% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 21.8 | +21.5% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 21.1 | +54.1% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 19.9 | +64.5% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 21.8 | +145.3% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 17.9 | +71.6% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 13.7 | +105.6% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 12.1 | +53.4% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 8.88 | -26.0% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 10.4 | -17.9% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 6.66 | -47.6% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 7.89 | -31.0% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 12 | -3.1% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 12.7 | +44.5% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 12.7 | +115.3% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 11.4 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 12.4 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 8.80 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 5.90 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Alpine Immune Sciences ($M), quarterly Q1 2018–Q1 2024 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/alpine-op-exp
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.